Other
2029
Biogen 2029 increased by 9.5% to $575.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $630.00M to $575.00M. Over 3 years (FY 2020 to FY 2023), 2029 shows an upward trend with a 31.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
Consistent projections allow for better predictability of future earnings and non-cash charges.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2029. It is a forward...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a9462eHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $225.00M | $195.00M | $195.00M | $195.00M | $195.00M | $190.00M | $190.00M | $175.00M | $175.00M | $440.00M | $485.00M | $685.00M | $680.00M | $585.00M | $630.00M | $630.00M | $525.00M | $575.00M |
| QoQ Change | — | -13.3% | +0.0% | +0.0% | +0.0% | -2.6% | +0.0% | -7.9% | +0.0% | +151.4% | +10.2% | +41.2% | -0.7% | -14.0% | +7.7% | +0.0% | -16.7% | +9.5% |
| YoY Change | — | — | — | — | -13.3% | -2.6% | -2.6% | -10.3% | -10.3% | +131.6% | +155.3% | +291.4% | +288.6% | +33.0% | -8.0% | -7.4% | -10.3% | -8.7% |
Range$175.00M – $685.00M
CAGR+24.7%
Avg YoY Growth+59.0%
Median YoY Growth-5.0%
2029 at Other Companies
Frequently Asked Questions
- What is Biogen's 2029?
- Biogen (BIIB) reported 2029 of $575.00M in Q1 2026.
- How has Biogen's 2029 changed year-over-year?
- Biogen's 2029 decreased by 8.7% year-over-year, from $630.00M to $575.00M.
- What is the long-term trend for Biogen's 2029?
- Over 3 years (2020 to 2023), Biogen's 2029 has grown at a 31.1% compound annual growth rate (CAGR), from $215.00M to $485.00M.
- What does 2029 mean?
- The expected non-cash expense for acquired intangible assets in the year 2029.